[
1. Balciūniene N., Tamasauskas A., Valanciūte A., Deltuva V., Vaitiekaitis G., Gudinaviciene I., Weis J., von Keyserlingk D.: Histology of human glioblastoma transplanted on chicken chorioallantoic membrane. Medicina (Kaunas) 2009, 45, 123-131.10.3390/medicina45020016
]Search in Google Scholar
[
2. Balke M., Neumann A., Kersting C., Agelopoulos K., Gebert C., Gosheger G., Buerger H., Hagedorn M.: Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane. BMC Res Notes 2010, 3, 58.10.1186/1756-0500-3-58283890620202196
]Search in Google Scholar
[
3. Barth R.F.: Rat brain tumour models in experimental neuro- oncology: the 9L, C6, T9, F98, RG2. (D74), RT-2 and CNS-1 gliomas. J Neurooncol 1998, 36, 91-102.
]Search in Google Scholar
[
4. Candolfi M., Curtin J.F., Nichols W.S., Muhammad A.K.M.G., King G.D., Pluhar E., McNiel E.A., Ohlfest J.R., Freese A.B., Moore P.F., Lerner J., Lowenstein P., Castro M.G.: Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterisation and tumour progression. J Neurooncol 2007, 85, 133-148.10.1007/s11060-007-9400-9238423617874037
]Search in Google Scholar
[
5. Cloughesy T.: The impact of recent data on the optimisation of standards of care in newly diagnosed glioblastoma. Semin Oncol 2011, 38, 11-20.10.1053/j.seminoncol.2011.09.00722078643
]Search in Google Scholar
[
6. Damia G., D’Incalci M.: Contemporary pre-clinical development of anticancer agents - what are the optimal preclinical models? Eur J Cancer 2009, 45, 2768-2781.10.1016/j.ejca.2009.08.00819762228
]Search in Google Scholar
[
7. Durupt F., Koppers-Lalic D., Balme B., Budel L., Terrier O., Lina B., Thomas L., Hoeben R.C., Rosa-Calatrava M.: The chicken chorioallantoic membrane tumour assay as model for qualitative of oncolytic adenoviruses. Cancer Gene Ther 2012, 19, 58-68.10.1038/cgt.2011.6822015640
]Search in Google Scholar
[
8. Fischbach C., Kong H.J., Hsiong S.X., Evangelista M.B., Yuen W., Mooney D.J.: Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci USA 2009, 106, 399-404.10.1073/pnas.0808932106262671419126683
]Search in Google Scholar
[
9. Grodzik M., Sawosz E., Wierzbicki M., Orlowski P., Hotowy A., Niemiec T., Szmidt M., Mitura K., Chwalibog, A.: Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo. Int J Nanomed 2011, 6, 3041-3048.10.2147/IJN.S25528323057022162660
]Search in Google Scholar
[
10. Hagedorn M., Javerzat S., Gilges D., Meyre A., de Lafarge B., Eichmann A., Bikfalvi A.: Accessing key steps of human tumour progression in vivo by using an avian embryo model. Proc Natl Acad Sci USA 2005, 101, 1643-1648.10.1073/pnas.040862210254784915665100
]Search in Google Scholar
[
11. Laurin T., Smitz U., Riediger D., Frank H.G., Stoll C.: Chorioallantoic membrane of fertilised avian eggs as a substrate for assessment of cancerous invasiveness. Mund Kiefer Gesichtschir 2004, 8, 223-228.10.1007/s10006-004-0543-y15293117
]Search in Google Scholar
[
12. Morton C.L., Houghton P.J.: Establishment of human tumour xenografts in immunodeficient mice. Nat Protoc 2007, 2, 247-250.10.1038/nprot.2007.25
]Search in Google Scholar
[
13. MacDonald I.C., Schmidt E.E., Morris V.L., Chambers A.F., Groom A.C.: Intravital videomicroscopy of the chorioallantoic microcirculation: a model system for studying metastasis. Microvasc Res 1992, 44, 185-199.10.1016/0026-2862(92)90079-5
]Search in Google Scholar
[
14. Szmidt M., Urbańska K., Grodzik M., Orłowski P., Sawosz E., Wierzbicki M., Sysa P.: Morphology of human glioblastoma model cultured in ovo. Bull Vet Inst Pulawy 2012, 56, 261-266.10.2478/v10213-012-0046-9
]Search in Google Scholar
[
15. Valle-Folguera J.M., Mascarenhas L., Costa J.A., Vieira F., Soares-Fernandes J., Beleza P., Alegria C.: Giant cell glioblastoma: review of the literature and illustrated case. Neurocirugía 2008, 19, 343-349.10.1016/S1130-1473(08)70221-5
]Search in Google Scholar
